OMB Proposes Rule Requiring Political Review of Every Federal Grant, Demoting Scientific Peer Review to "Advisory"

Details

On May 29, 2026, the Office of Management and Budget (OMB)—led by Director Russell Vought, a Trump appointee and a principal architect of the administration's executive-power agenda through Project 2025—published a proposed rule titled "Regulation for Federal Financial Assistance" (91 FR 32198, document number 2026-10817, docket OMB-2026-0034). The proposal would rewrite the Uniform Guidance—the standardized set of rules codified at 2 CFR Part 200 that governs how federal agencies award and administer grants and other financial assistance. Because the Uniform Guidance applies government-wide, the rewrite would reach an estimated 40-plus grantmaking agencies, including the National Institutes of Health, the National Science Foundation, NASA, the Department of Energy, and the Department of Defense, and would touch nearly every dollar of federal support for scientific research.

The proposal is the regulatory culmination of a policy the administration began building in 2025. Where earlier moves—grant cancellations, agency layoffs, and proposed budget cuts—operated case by case and drew legal challenges, this rule would embed political oversight of grantmaking into the permanent framework that all future administrations inherit.

Because the Uniform Guidance is the common rulebook for essentially all federal grants, the rewrite's reach extends well past laboratories. The same political-review and at-will-termination provisions would apply to the far larger flows of federal money that pass through the states—Medicaid, transportation, K–12 education aid, and food assistance among them. Elizabeth Ginexi, a former NIH program director who spent 22 years overseeing federally funded science, wrote that "federal grants are not peripheral to how states and communities function," noting that they represent, "on average, 36 cents of every dollar a state spends," and warning that the proposal would place the financial partnership between the federal government and the states "under political control, without an act of Congress."

What the Proposed Rule Would Do

According to the text of the proposal and analyses by legal and scientific organizations, the rewrite makes several structural changes to how discretionary grants are decided and administered.

Alignment with administration priorities. The rule would require that grant program goals be, in its words, "aligned with administration policies and priorities" (§ 200.202). Funding opportunity announcements—the solicitations agencies publish to invite applications—would have to reflect those priorities, and agencies could in some cases keep opportunities from being publicly posted when they judged that publication was not in the "national interest."

Senior appointee review; peer review demoted to advisory. The proposal directs that "senior appointees must conduct these reviews" to ensure "that discretionary awards advance the President's policy priorities," while specifying that "peer review remains advisory and does not replace agency discretion" (§ 200.205). In practice this would formalize a shift already begun under the 2025 executive order: the traditional system in which panels of outside subject-matter experts score proposals on scientific merit would become one input, subordinate to sign-off by politically appointed officials.

Termination when priorities change. The rule would allow an agency to terminate an award whenever it determines the grant "no longer effectuates program goals, Federal agency priorities, or the national interest as they exist at the time of the termination" (§ 200.340). The phrase "as they exist at the time of the termination" is what critics single out: it ties a grant's continued survival not to the terms under which it was awarded, but to whatever the agency's priorities happen to be at any later moment.

Subrecipient conduct and reputation. The proposal would require prime recipients—typically universities—to ensure that their subrecipients do not take actions that "significantly damage the reputation of … the Federal Government" (§ 200.332), a provision critics have characterized as a vague loyalty or reputational clause with no clear standard.

Additional restrictions. Coverage of the rule reported that it would also bar the use of grant funds for a range of specific purposes, including activities involving racial preferences or "disparate-impact" analysis, certain topics related to gender identity, international collaborations not specifically justified, and open-access publication and article-processing fees—the last of which scientific societies warn would restrict how publicly funded research is shared. Colette Delawalla, who heads the group Stand Up for Science, argued the collaboration restriction would reach much of modern science, telling the New Yorker that "by this guidance, America would not be allowed to be included in the International Space Station," and that "the same goes for every type of weather monitoring and pandemic monitoring."

The Executive Order That Preceded It

The proposed rule did not appear from nowhere. On August 7, 2025, President Trump signed Executive Order 14332, "Improving Oversight of Federal Grantmaking" (published August 12, 2025, 90 FR 38929). The order directed each agency head to designate a senior appointee to build a review process for new funding announcements and discretionary grants, and instructed that senior appointees apply "independent judgment" rather than "ministerially ratify or routinely defer to the recommendations of others."

Under the order, "discretionary awards must, where applicable, demonstrably advance the President's policy priorities," and awards were prohibited from funding racial preferences, the "denial" of biological sex, illegal immigration, or initiatives that "compromise public safety or promote anti-American values." It also tied grantmaking to the administration's "Gold Standard Science" initiative and directed agencies to revise standard grant terms to permit "immediate termination for convenience" when awards "no longer advance agency priorities or the national interest." Agencies were given 30 days to report their existing termination provisions and active-award counts to OMB.

Legal advisories at the time—from firms including Arnold & Porter and Holland & Knight—advised grant recipients that the order significantly expanded political oversight of awards and introduced new termination risk. The May 2026 proposed rule would convert those executive-order directives into durable regulation, applying them across the government through the Uniform Guidance rather than through a directive that a future president could rescind with the stroke of a pen.

The Administration's Rationale

OMB framed the rewrite as a good-government measure. The preamble emphasizes improving transparency, accountability, and oversight; clarifying the regulatory status of the Uniform Guidance; reducing burden on recipients; and ensuring, in the agency's words, that "American tax dollars are not wasted or misused" and that activities funded by grants "are consistent with law and policy." Supporters point to longstanding, bipartisan complaints that the Uniform Guidance is complex and that federal grant compliance is burdensome, and to the administration's stated aim of tightening recipient vetting and verification to combat "waste, fraud, and abuse." OMB Director Russell Vought, who oversaw the rewrite, defended it at congressional hearings in June 2026, telling lawmakers it was designed to bring grantmaking into line with Executive Order 14332—an acknowledgment that the rule is an instrument of the administration's political priorities rather than a career-staff initiative. The administration's nominee for OMB deputy director, Hal Duncan, was more explicit still at his own confirmation hearing, noting that the proposal would let the administration keep federal money from supporting "divisive D.E.I. ideologies." The Uniform Guidance itself is a career-administered framework revised periodically to reflect the sitting administration's aims; the prior revision, in April 2024 under President Biden's OMB, focused on plain-language rewrites and higher dollar thresholds, not political review.

The administration also offered a more overtly political justification. In the preamble, OMB wrote that "in the previous administration, executive agencies frequently chose to subsidize and expressly prioritize projects based on their ideological alignment," and argued that "if executive agencies were entitled to subsidize those types of activities during the previous administration, there is no constitutional basis to prevent the government from reaching a different policy determination regarding which activities to fund during this administration." In other words, the administration contends it is exercising the same discretion its predecessor did, in a different direction—a symmetry argument that is central to its legal and political defense of the rule.

The Central Criticism: Permanent Politicization

The sharpest objection is not that a given administration sets funding priorities—every administration does—but that the rule would institutionalize case-by-case political review of individual awards, in perpetuity, for whichever party holds power. Alex Tabarrok, a libertarian economist at George Mason University who is not generally aligned with the political left, called the proposal "the nationalization of American science." He summarized it as "political review of every award, peer review demoted, agency review promoted, termination whenever 'priorities' change," and warned: "One dial in the White House now turns every grant program in the country."

Critics note the symmetry argument cuts both ways. Because the rule would remain on the books across administrations, a future Democratic president would inherit the same power to screen every federal grant for political alignment and could staff the review process with appointees applying opposite criteria. Under that reading, whichever party is doing the screening in a given year, the structural loser is the independence and predictability of the scientific enterprise itself.

Scientists also warn the mechanism collides with how research actually works: grants underwrite projects that run for years, while political priorities can shift every two to four years. Making awards terminable based on priorities "as they exist at the time of the termination" injects, in critics' view, precisely the kind of instability that long-horizon research is designed to be insulated from.

Reaction

The proposal drew an extraordinary public response. According to Eos, the rule had drawn more than 98,900 comments by July 9, 2026, and by the July 13 deadline the total had reached roughly 300,000, Inside Higher Ed reported—an extraordinarily high volume for a federal grants regulation. (Comment tallies varied by source and date because regulations.gov publishes submissions well after receiving them; many comments are received but not immediately posted.) A Tech Policy Press analysis of the roughly 51,000 comments that had been published as of July 9 found that about 94 percent opposed the rule and 6 percent supported it. The analysis also found the opposition was overwhelmingly grassroots—only about 16 percent of comments were form letters—whereas roughly 87 percent of the supportive comments came from a single coordinated form-letter campaign.

Scientific societies, universities, and journal editors mounted organized opposition. As Inside Higher Ed reported, Science editor-in-chief Holden Thorp wrote to readers, "All hands, report to stations," and the New England Journal of Medicine compared the proposal to Lysenkoism—the Soviet subordination of biology to ideology—warning that "allowing politics to control the scientific process can halt or reverse a nation's progress." Amanda Fuchs Miller, a former Biden administration official, questioned the internal logic of retaining merit review while overriding it: "Why would you do the peer review if you're not going to use it to give out the awards?"

Several Nobel laureates submitted comments in opposition. Wolfgang Ketterle of the Massachusetts Institute of Technology, a co-recipient of the 2001 Nobel Prize in Physics, wrote that the regulations would "destroy the leadership of the U.S. in fundamental science," arguing that even research the administration now prizes had taken decades to mature: "I work on quantum science which is NOW a priority of the administration. But it took twenty years to develop the foundations, before it became clear that this can lead to novel quantum technologies." Martin Chalfie, a Columbia University professor and 2008 Nobel laureate in chemistry, wrote that his own "Nobel Prize–winning research was made possible by a peer-reviewed grant from [the National Institutes of Health]," and warned that "having grants pass a political litmus test will destroy science."

Advocacy groups and scientific associations warned that the effects would reach well beyond laboratories. Elizabeth Jacobs, a professor emerita at the University of Arizona and a coordinating-committee member of Defend Public Health, said in a statement that the proposed rule "terrifies me" and could "turn everything into a political football." The American Meteorological Society cautioned that the changes would "damage the nation's ability to understand, predict, and respond to severe weather, drought, and other natural hazards with negative impacts on public safety and the economy." And the American Association for Cancer Research argued that the existing framework had helped cut the U.S. cancer death rate by 35 percent since 1991—"more than 4.8 million U.S. lives saved"—precisely because funding decisions were "guided by the rigorous review of grant applications by scientific experts … NOT guided by political and ideological considerations." Sudip Parikh, chief executive of the American Association for the Advancement of Science, called the proposal "a brazen power grab by the Director of the Office of Management and Budget to buck the will of Congress and the American people" that "will make future discoveries less likely."

Opposition also came from the organizations that administer federal grants on the ground, underscoring that the rule's reach extends well beyond the laboratory. The National League of Cities warned that mid-award terminations "disrupt services and strain local budgets" and objected that the rule would permit "federal over-reach into choices and values best determined at the local level," while the National Council of Nonprofits urged OMB to withdraw the rule outright and the School Superintendents Association raised parallel concerns about the effect on schools and community programs.

Congressional Democrats objected in unison. Every Senate Democrat signed a letter charging that the rule would hand the President a "new cudgel" to "advance his partisan agenda and punish political rivals," and Senator Patty Murray of Washington accused the White House of trying "to turn the entire federal government into this one big slush fund to reward those aligned with the Administration and punish everyone else."

Scientific organizations filed formal comments in opposition. Geoscientist Hannah Mark warned that the rule "turns grantmaking into an entirely political process" and would cause the United States to "quickly lose our status as a leading scientific power." American Geophysical Union president Brandon Jones said the proposal would "restructure the foundational rules of U.S. science funding … to serve political priorities rather than the public good." The American Physical Society, the Association of American Medical Colleges, and other bodies urged members to submit comments opposing the changes.

Georgetown health-law scholar Andrew Twinamatsiko told STAT that the shift to regulation marked a strategic change: whereas 2025's disruptions were "tempests that we could weather until there's a new administration," a rule woven into the Uniform Guidance is designed to be more durable and harder to reverse.

Public Support for Science

The overhaul is unfolding against a backdrop of broad, bipartisan public support for science. A Pew Research Center survey released in January 2026 found that 77% of U.S. adults have at least "a fair amount" of confidence in scientists to act in the public's best interests—rating them roughly on par with the military and above journalists, business leaders, and elected officials. Confidence runs higher among Democrats (90%) than Republicans (65%), and Republican confidence fell about 22 percentage points during the pandemic (from April 2020 to December 2021) before stabilizing, but a clear majority of Republicans still express it. Support for public funding is similarly broad: 84% of Americans—including 76% of Republicans and 93% of Democrats—call government investment in scientific research worthwhile, though a slight majority of Republicans (54%) say private investment alone could ensure sufficient progress. The polling is a relevant backdrop because the rule is framed in part as a corrective to ideologically captured science: public trust in scientists remained high and bipartisan even as the administration moved to restructure how their work is funded.

What Is Genuinely Uncertain

Several caveats matter for an honest assessment. The Uniform Guidance is revised periodically, and OMB has clear legal authority to propose changes to it; the prior administration issued its own major revision in 2024. Administrations have always set research priorities and have always retained discretion over discretionary (as opposed to formula or entitlement) awards, and federal awards have long included "termination for convenience" clauses. Some of the rule's stated aims—reducing compliance burden, tightening oversight of misused funds—command broad support in principle.

The elements critics identify as new and dangerous are more specific: elevating senior political appointees over expert peer review for individual award decisions across the entire government; keying continued funding to shifting "national interest"; and the reputational subrecipient clause. Whether those provisions survive intact, get softened in a final rule, or are struck or narrowed by courts is unknown. So is their practical effect: because the rule is not final, no grant has yet been decided or terminated under it, and much depends on how aggressively agencies would use the discretion the rule grants.

Status

As of mid-July 2026, the proposed rule was not finalized. The public comment period closed on July 13, 2026, after drawing roughly 300,000 comments, and OMB must review and respond to significant comments before issuing any final rule. Legal advocacy groups—including Democracy Forward, Lawyers for Good Government, and Public Citizen—said they were prepared to challenge the rule in court once it is finalized, while OMB has signaled it wants the new requirements to take effect by October 1, 2026. The August 2025 executive order that preceded the rule, however, remains in effect, and its senior-appointee review requirements are already being implemented at grantmaking agencies—one likely contributor to the sharp slowdown in NIH and NSF grant awards documented over the same period. The rule's ultimate scope, its durability against expected legal challenges, and its long-run effect on the independence of American science all remain open.